Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Jian Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3320-7924; OpenAlex author ID A5100402608. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2013: 1 paper · 2014: 3 papers · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 9

  1. Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. Co-author DOI 10.3892/mmr.2023.12943↗
  2. Long non-coding RNA DANCR regulate MLL3 and thereby it determines the progression of pancreatic cancer. First author PMID 33099938↗
  3. LncRNA TP73-AS1 sponges miR-141-3p to promote the migration and invasion of pancreatic cancer cells through the up-regulation of BDH2. Co-author DOI 10.1042/bsr20181937↗
  4. miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein… Co-author DOI 10.1089/dna.2017.3656↗
  5. Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma. First author DOI 10.18632/oncotarget.19578↗
  6. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Co-author DOI 10.1016/j.canlet.2013.10.009↗
  7. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer. Co-author DOI 10.3892/mmr.2014.2558↗
  8. [Application of miRNAs in the occurrence and early diagnosis of pancreatic cancer]. Co-author PMID 24785459↗
  9. MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. Co-author DOI 10.1007/s12253-013-9637-x↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaizhi Wang · 3 shared papers, 2014–2023 · strength 0.34
  2. Bing Ni · 2 shared papers, 2017–2023 · strength 0.30
  3. Wenhua Li · 1 shared paper, 2023 · strength 0.24
  4. Yongkang Liu · 1 shared paper, 2023 · strength 0.24
  5. Yuxin Chen · 1 shared paper, 2020 · strength 0.13
  6. Yang Liu · 1 shared paper, 2020 · strength 0.13
  7. Chengkun Qin · 1 shared paper, 2019 · strength 0.11
  8. Xianping Cui · 1 shared paper, 2019 · strength 0.11
  9. Zhiyi Wang · 1 shared paper, 2019 · strength 0.11
  10. Yongsheng Ouyang · 2 shared papers, 2014–2017 · strength 0.10
  11. Shixiang Guo · 2 shared papers, 2014–2017 · strength 0.10
  12. Kemin Wu · 2 shared papers, 2013–2014 · strength 0.09
  13. Weijia Sun · 2 shared papers, 2013–2014 · strength 0.09
  14. Jianguo Wang · 1 shared paper, 2017 · strength 0.08
  15. Yunchao Wang · 1 shared paper, 2017 · strength 0.06
  16. Xin Zhao · 1 shared paper, 2017 · strength 0.06
  17. Huan Qin · 1 shared paper, 2017 · strength 0.06
  18. Zhiping Zhao · 1 shared paper, 2017 · strength 0.06
  19. Wenjie Huang · 1 shared paper, 2017 · strength 0.06
  20. Songsong Liu · 1 shared paper, 2017 · strength 0.06
  21. Shujun Xia · 1 shared paper, 2014 · strength 0.06
  22. Li Zhou · 1 shared paper, 2014 · strength 0.06
  23. Yupei Zhao · 1 shared paper, 2014 · strength 0.06
  24. Junchao Guo · 1 shared paper, 2014 · strength 0.06
  25. Kun Song · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.